Inflammatory cytokine mRNAs in surgical specimens of necrotizing enterocolitis and normal newborn intestine

Pediatric Pathology and Laboratory Medicine

Volumn 17, Issue 4, 1997, Pages 547-559

  Viscardi, Rose M ^a   Lyon, Nancy H ^a   Sun, Chen Chih J ^a   Richard Hebel, J ^a   Hasday, Jeffrey D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Interleukin 6; Interleukin 8; Interleukin l ; Necrotizing enterocolitis; Prematurity; Tumor necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANASTOMOSIS; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IN SITU HYBRIDIZATION; INFLAMMATION; INTESTINE MALFORMATION; NECROTIZING ENTEROCOLITIS; NEUTROPHIL CHEMOTAXIS; NEWBORN; ONSET AGE; PREMATURITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

CYTOKINES; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; INFANT, NEWBORN; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; INTESTINES; MALE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030979475     PISSN: 10771042     EISSN: None     Source Type: Journal    
DOI: 10.1080/107710497174516     Document Type: Article

References (42)

1. Hennés HM, Lee MB, Rimm AA, Shapiro DL. Surfactant replacement therapy in respiratory distress syndrome. AmJ Dis Child 1991;145:102-4.
2. Allen MC, Donohue PK. The limit of viability-neonatal outcome of infants born at 22 to 25 weeks' gestation. N EnglJ Med 1993:329:1597-601.
3. Caplan MS, MacKendrick W. Necrotizing enterocolitis: A review of pathogenetic mechanisms and implications for prevention. Pediatr Pathol 1993;13:357-69.
4. Uauy R, Fanaroff AA, Korones SB, Phillips EA, PhilipsJB, Wright LL. Necrotizing enterocolitis in very low birth weight infants: Biodemographic and clinical correlates. J Pediatr 1991 ;119:630-8.
5. Investigators V-OTN. The Vermont-Oxford trials network: Very low birth weight outcomes for 1990. Pediatrics 1993;91:540-5.
6. Stoll BJ. Epidemiology of necrotizing enterocolitis. Clin Perinatol 1994;21:205-18.
7. Kleigman RM, Walsh MC. Neonatal necrotizing enterocolitis: Pathogenesis, classification, and spectrum of illness. Curr Probl Pediatr 1987:17:213-88.
8. Clark DA, Miller MJS. Intraluminal pathogenesis of necrotizing entrocolitis. J Pediatr 1990;! 17:S64-7.
9. Crissinger KD. Animal models of necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 1995:20:17-22.
10. Kosloske AM. Epidemiology of necrotizing enterocolitis. Acta Paediatr Suppl 1994;396:2-7.
11. Israel EJ, Neonatal necrotizing enterocolitis, a disease of the immature intestinal mucosal barrier. Acta Paediatr Suppl 1994;396:27-32.
12. Ballance WA, Dahms BB, Shenker N, Kleigman RM. Pathology of neonatal necrotizing enterocolitis: A ten-year experience.] Pediatr 1990;! 17:86-13.
13. Wong GG, Clark SC. Multiple actions of interleukin 6 within a cytokine network. Immunol Today 1988:9:137-9.
14. Baggiolini M, WaizA, Kunkel SL. Neutrophil-activating peptide-1 /interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-9.
15. LeJ, VilcekJ. Tumor necrosis factor and interleukin 1 : Cytokines with multiple overlapping biological activities. Lab Invest 1987:56:234-7.
16. MorecroftJA, Spitz L, Hamilton PA, Holmes SJK. Plasma interleukin-6 and tumor necrosis factor levels as predictors of disease severity and outcome in necrotizing enterocolitis. J Pediatr Surg 1994:29:798-800.
17. Harris MC, Costarino AT, Sullivan JS, et al. Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis. ] Pediatr 1994;124:105-11.
18. Birk D, Berger D, LimmerJ, Beger HG. Is the elimination of endotoxin and cytokines with continous lavage an alternative procedure in necrotizing enterocolitis? Acta Paediatr Suppl 1994:396:24-6.
19. Deitch EA. Role of bacterial translocation in necrotizing enterocolitis. Acta Paediatr Suppl 1994:396:33-6.
20. McCrea KA, Ensor JE, Nail K, Bleecker ER, HasdayJD. Altered cytokine regulation in the lungs of cigarette smokers. AmJ Respir Crit Care Med 1994; 150:696-703.
21. Conover WJ, Iman RL. Rank transformations as a bridge between parametric and nonparametric statistics. Am Statist 1981:35:124-9.
22. Kozol RA. Neutrophil recruitment to the gastrointestinal tract. J Surg Res 1992;53:310-15.
23. Rachmilewitz D, Simon PE, Schwarte LW, Griswold DE, FondacaroJD, Wasserman MA. Inflammatory mediators of experimental colitis in rats. Gastroenterology 1989:97:326-37.
24. Schuerer-Maly CC, Eckmann L, Kagnoff MF, Falco MT, Maly FE. Colonie epithelial cell lines as a source of interleukin-8: Stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunology 1994;81:85-91.
25. Caplan MS, MacKendrick W. Inflammatory mediators and intestinal injury. Clin Perinatol 1994:21:235-46.
26. Caplan MS, Kelly A, Hsueh W. Endotoxin and hypoxia-induced intestinal necrosis in rats: The role of platelet activating factor. Pediatr Res 1992:31:428-34.
27. Caplan MS, Sun X, Hsueh W, Hageman [R. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis.J Pediatr 1990:116:960-4.
28. Morecroft JA, Spitz L, Hamilton PA, Holmes SJK, Plasma cytokine levels in necroti/ing enterocolitis. Acta Paediatr Suppl 1994;396:18-20.
29. Tan X, Hsueh W, Gomalez-Crussi F. Cellular localization of tumor necrosis factor (TNF)-a transcripts in normal bowel and in necrotizing enterocolitis. TNF gene expression by Paneth cells, intestinal eosinophils, and macrophages. AmJ Pathol 1993:142:1858-65.
30. Beutler B. The complex regulation and biology of TNF (cachectin). Oncogenesis 1990:2:9-18.
31. Dinarello CA, WolffSM. The role of interluekin-1 in disease. N EnglJ Med 1993:328:106-13.
32. Contrino J, Krause PJ, Slover N, Kreutzer D. Elevated imerleukin-1 expression in human neonatal neutrophils. Pediatr Res 1993:34:249-52.
33. Schindler R, Mancilla J, Endres S. Ghorbani R, Clark SC, Dinarello CA. Correlations and interactions in the production of interleukin-6 (IL-6), II.-l, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990:75:40-7.
34. Zoja C, Wang JM, Bettoni S, et al. Interletikin-1 βand tumor necrosis factor-ex induced gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells. AmJ Pathol 1991;133:991-1003.
35. Mazzucchelli L, Hauser C, Zgraggen K, etal. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. AmJ Pathol 1994;144:997-1007.
36. Aderka D, Le J, Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 1989:143:3517-23.
37. Barton BE, Jackson JV. Protective role of interleukin-6 in the lipopolysaccharide-galactosamine septic shock model. Infect Immun 1993:61:1496-9.
38. Yachie A, Takano N, Ohta K, et al. Defective production of interleukin-6 in very small premature infants in response to bacterial pathogens. Infect Immun 1992:60:749-53.
39. Ulich TR, Guo K, Irwin B, Remick DG, Davatelis ON. Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and interleukin-la/β expression and suppression. Am J Pathol 1990:137:1173-85.
40. Rambaldi A, Bettoni S, Rossi V, etal.Transcriptionalandpost-transcriptional regulation of II.-Iβ, IL-6 and TNF-α genes in chronic lymphocytic leukaemia. Br J Haematol 1993:83:204-11.
41. Zhong WW, Burke PA, Hand AT, Walsh MJ, Hughes LA, Forse RA. Regulation of cytokine mRNA expression in lipopolysaccharide-stimulated human macrophages. Arch Surg 1993:128:158-64.
42. Wolf HM, Eibl MM. The anti-inflammatory effect of an oral immunoglobulin (IgA-IgG) preparation and its possible relevance for the prevention of necroti/ing enterocolitis. Acta Paediatr Suppl 1994:396:37-40.